LOS ANGELES, CALIFORNIA -- (Marketwired) -- 07/29/15

Convalo Health International, Corp. ("Convalo") (TSX VENTURE: CXV), a company focused on rolling up the highly-fragmented addiction recovery sector in the US, at the request of the Investment Industry Regulatory Organization of Canada (IIROC), wishes to confirm that its management is unaware of any material change in Convalo's operations that would account for the recent decrease in its stock price.

About Convalo

Convalo is an acquisition-oriented company focused on rolling up the US outpatient addiction rehabilitation market led by seasoned management with experience in both US healthcare acquisitions and healthcare service asset management. In May 2014, Convalo made its first acquisition of a small, local addiction rehabilitation center in Los Angeles. Since May, the business has operated under the brand name BLVD Centers (www.blvdcenters.com) in a luxury Hollywood, California location. BLVD offers patients access to a wide range of services, including addictive and co-occurring disorders, helpful to the recovery process. In conjunction with the 12-Step approach, BLVD also offers supplemental insurance-reimbursed services catering to a variety of communities: gender specific, creatively-oriented, meditation/mindfulness, trauma and LGBT affirmative.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Convalo Health International, Corp.
Dennis Wilson
Corporate Affairs
(323) 844-1298
investorinfo@convalohealth.com
www.convalohealth.com